Xi Shi

Xi Shi

Auto-generated profile, based on publicly available information

Xi Shi

Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2018 in Science
Verified
Journal Article
Closed access
PDF file
HNHiroshi Nishimasu
Hiroshi Nishimasu
XSXi Shi
Xi Shi
SISoh Ishiguro
Soh Ishiguro
LGLinyi Gao
Linyi Gao
SHSeiichi Hirano
Seiichi Hirano
ONOsamu Nureki
Osamu Nureki
Expanding the targeting space of Cas9: CRISPR-Cas9 associates with a guide RNA to target and cleave a specific DNA site next to a protospacer adjacent motif (PAM). Streptococcus pyogenes Cas9 (SpCas9), the one most often used for genome editing, only recognizes the NGG sequence (where N is any nucleobase) as the PAM, which restricts regions in the genome that can be targeted. To address this limitation, Nishimasu et al. created a SpCas9 variant that recognizes NG rather than NGG. The SpCas9-NG variant increased the targeting range, had a specificity similar to that of the wild-type enzyme, and could be used with a base editor. Thus, SpCas9-NG is a powerful addition to the CRISPR-Cas9 genome engineering toolbox and will be useful in a broad range of applications, from basic research to clinical therapeutics. Science , this issue p. 1259

20 May 2020 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
PMPatrick K. McCamphill
Patrick K. McCamphill
LSLaura J. Stoppel
Laura J. Stoppel
RSRebecca K. Senter
Rebecca K. Senter
MLMichael C. Lewis
Michael C. Lewis
AHArnold J. Heynen
Arnold J. Heynen
MBMark F. Bear
Mark F. Bear
Selective inhibition of GSK3α corrects diverse impairments in theFmr1−/ymouse model of fragile X syndrome.